SPDR S&P Biotech (XBI)
AMEX
Year End June 29 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | 0.336 | 0.268 | 0.209 | -10.221 | 19.149 | 16.522 | -50.021 | 10.103 |
Return on Equity (%) | 0.411 | 0.303 | 0.231 | -11.188 | 21.379 | 18.736 | -55.101 | 11.038 |
Return on Invested Capital (%) | -3.298 | 322.968 | 336.16 | 194.412 | 7.417 | 186.652 | -299.444 | -534.235 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 54.157 | 77.152 | 95.232 | 87.818 | 112.03 | 135.539 | 74.235 | 83.253 |
Earnings Per Share | 0.275 | 0.179 | 0.185 | -10.738 | 21.757 | 22.153 | -42.13 | 9.473 |
Cash Per Share | N/A | 0.728 | N/A | N/A | N/A | 0.152 | N/A | N/A |
Working Capital Per Share | 0.025 | 0.092 | 0.033 | 0.011 | 0.154 | 0.105 | 0.023 | 0.011 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 0.552 | 0.347 | 0.372 | -10.639 | 21.776 | 22.438 | -42.13 | 9.476 |
Year End June 29 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 1.002 | 1.015 | 1.003 | 1.002 | 1.009 | 1.007 | 1.004 | 1.001 |
Quick Ratio | 1.001 | 1.011 | 1 | 1 | 1.007 | 1.005 | 1.003 | 1 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 34.6M | 46M | 54.95M | 50.25M | 48.23M | 53.53M | 92.2M | 77.43M |
Year End June 29 2023 | ||||||||
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Market Cap | 7.55B |
Price to Earnings Ratio | 10.29 |
Price to Sales Ratio | 411.96 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 1.17 |
Dividend Yield | - |
Shares Outstanding | 77.43M |
Average Volume (1 week) | 9.69M |
Average Volume (1 Month) | 8.17M |
52 Week Change | 13.48% |
52 Week High | 103.52 |
52 Week Low | 63.80 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.